advertisement

---

Di Maria A 11

Showing records 1 to 11 | Display all abstracts from Di Maria A

128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Di Maria A
Clinical Ophthalmology 2025; 19: 2383-2391

---

127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Ferraro V
Clinical Ophthalmology 2025; 19: 2295-2303

---

128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Ferraro V
Clinical Ophthalmology 2025; 19: 2383-2391

---

127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Gaeta A; Barone G
Clinical Ophthalmology 2025; 19: 2295-2303

---

128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Barone G; Vitali M
Clinical Ophthalmology 2025; 19: 2383-2391

---

127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Confalonieri F
Clinical Ophthalmology 2025; 19: 2295-2303

---

128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Tredici C
Clinical Ophthalmology 2025; 19: 2383-2391

---

127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Tredici C; Vinciguerra P
Clinical Ophthalmology 2025; 19: 2295-2303

---

128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Gaeta A; Vinciguerra P
Clinical Ophthalmology 2025; 19: 2383-2391

---

127863 Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Di Maria A
Clinical Ophthalmology 2025; 19: 2295-2303

---

128267 Impact of Active Fluidics System on RNFL and GCL in Phacoemulsification
Confalonieri F
Clinical Ophthalmology 2025; 19: 2383-2391

---